| Investor | BML Investment Partners, L.P. |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by BML Investment Partners, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | 13G/A | OM / Outset Medical, Inc. | 2,196,701 | 2,519,701 | ||||
| 2026-05-14 | 13G/A | ENGN / enGene Therapeutics Inc. | 5,225,000 | 6,669,908 | ||||
| 2026-05-13 | 13G | ENGN / enGene Therapeutics Inc. | 5,225,000 | |||||
| 2026-05-12 | 13G/A | KZR / Kezar Life Sciences, Inc. | 0 | |||||
| 2026-05-12 | 13G/A | OM / Outset Medical, Inc. | 1,902,201 | 2,196,701 | ||||
| 2026-04-27 | 13G/A | ACRS / Aclaris Therapeutics, Inc. | 14,250,000 | 13,950,000 | ||||
| 2026-03-19 | 13G | TLYS / Tilly's, Inc. | 0 | 2,189,186 | ||||
| 2026-02-13 | 13G/A | OM / Outset Medical, Inc. | 1,705,876 | 1,902,201 | ||||
| 2026-02-09 | 13G/A | 720,787 | ||||||
| 2026-02-09 | 13G/A | TIL / Instil Bio, Inc. | 440,000 | 645,600 | ||||
| 2026-02-09 | 13G/A | PMVP / PMV Pharmaceuticals, Inc. | 3,466,684 | 5,292,000 | ||||
| 2026-02-09 | 13G/A | ORMP / Oramed Pharmaceuticals Inc. | 2,643,907 | 3,287,531 | ||||
| 2026-02-09 | 13G | AVIR / Atea Pharmaceuticals, Inc. | 7,216,312 | 7,810,000 | ||||
| 2026-02-09 | 13G/A | ACRS / Aclaris Therapeutics, Inc. | 14,250,000 | 14,250,000 | ||||
| 2026-01-14 | 13G | OM / Outset Medical, Inc. | 1,705,876 | |||||
| 2025-12-18 | 13G/A | 0 | ||||||
| 2025-12-09 | 13D/A | 0 | ||||||
| 2025-12-05 | 13D/A | 2,149,880 | ||||||
| 2025-11-10 | 13D/A | 3,249,326 | ||||||
| 2025-10-07 | 13D/A | ASTC / Astrotech Corporation | 232,065 | 0 | ||||
| 2025-07-28 | 13D/A | ELEV / Elevation Oncology, Inc. | 5,890,934 | 0 | ||||
| 2025-07-28 | 13D/A | IMA / ImageneBio, Inc. | 220,832 | |||||
| 2025-06-18 | 13D/A | ANTX / AN2 Therapeutics, Inc. | 3,217,423 | 427,432 | ||||
| 2025-06-16 | 13D | IKNA / Ikena Oncology, Inc. | 3,645,866 | 4,090,102 | ||||
| 2025-05-30 | 13D/A | ANTX / AN2 Therapeutics, Inc. | 5,749,432 | 3,217,423 | ||||
| 2025-05-20 | 13D | 3,249,326 | ||||||
| 2025-05-07 | 13D | ANTX / AN2 Therapeutics, Inc. | 5,749,432 | 5,749,432 | ||||
| 2025-05-06 | 13G/A | 2,882,317 | ||||||
| 2025-04-24 | 13D | EPIX / ESSA Pharma Inc. | 4,221,546 | 4,221,546 | ||||
| 2025-04-16 | 13D | ELEV / Elevation Oncology, Inc. | 5,890,934 | 5,890,934 | ||||
| 2025-03-26 | 13G | ELEV / Elevation Oncology, Inc. | 5,890,934 | |||||
| 2025-03-06 | 13G | 368,594 | ||||||
| 2025-03-05 | 13D/A | WHWK / Whitehawk Therapeutics, Inc. | 2,435,000 | 2,435,000 | ||||
| 2025-03-03 | 13G | LVTX / LAVA Therapeutics N.V. | 1,958,110 | |||||
| 2025-02-24 | 13D/A | WHWK / Whitehawk Therapeutics, Inc. | 2,435,000 | |||||
| 2025-02-14 | 13G | THRD / Third Harmonic Bio, Inc. | 3,724,167 | |||||
| 2025-02-14 | 13G/A | IKNA / Ikena Oncology, Inc. | 3,645,866 | |||||
| 2025-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 4,183,223 | 4,221,546 | ||||
| 2025-02-14 | 13G/A | ATHA / LeonaBio, Inc. | 2,484,445 | 3,027,163 | ||||
| 2025-02-14 | 13G/A | PMVP / PMV Pharmaceuticals, Inc. | 3,269,907 | 3,466,684 | ||||
| 2025-02-14 | 13G/A | PMVP / PMV Pharmaceuticals, Inc. | 3,269,907 | 3,269,907 | ||||
| 2025-02-14 | 13G/A | ATHA / LeonaBio, Inc. | 2,484,445 | 2,484,445 | ||||
| 2025-02-14 | 13G/A | EPIX / ESSA Pharma Inc. | 4,183,223 | 4,183,223 | ||||
| 2025-02-13 | 13G/A | ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) | 4,100,002 | 4,100,002 | ||||
| 2025-02-13 | 13G/A | ORMP / Oramed Pharmaceuticals Inc. | 2,048,634 | 2,643,907 | ||||
| 2025-02-13 | 13G/A | ANTX / AN2 Therapeutics, Inc. | 5,749,432 | 5,749,432 | ||||
| 2025-02-13 | 13G/A | TIL / Instil Bio, Inc. | 346,190 | 440,000 | ||||
| 2025-02-13 | 13G/A | CLYM / Climb Bio, Inc. | 2,350,682 | 0 | ||||
| 2025-02-13 | 13G/A | 2,206,346 | 2,373,404 | |||||
| 2025-02-13 | 13G/A | TECX / Tectonic Therapeutic, Inc. | 0 | |||||
| 2025-02-13 | 13G/A | ACRS / Aclaris Therapeutics, Inc. | 9,395,934 | 14,250,000 | ||||
| 2025-02-04 | 13D/A | WHWK / Whitehawk Therapeutics, Inc. | 2,435,000 | |||||
| 2025-01-30 | 13D | WHWK / Whitehawk Therapeutics, Inc. | 2,435,000 | |||||
| 2024-12-31 | 13D | WHWK / Whitehawk Therapeutics, Inc. | 1,383,817 | 2,435,000 | ||||
| 2024-12-31 | 13G | IKNA / Ikena Oncology, Inc. | 3,645,866 | |||||
| 2024-12-16 | 13D | AVIR / Atea Pharmaceuticals, Inc. | 5,602,079 | 7,216,312 | ||||
| 2024-12-12 | 13G | PMVP / PMV Pharmaceuticals, Inc. | 3,269,907 | |||||
| 2024-11-07 | 13G | ATHA / LeonaBio, Inc. | 2,484,445 | |||||
| 2024-11-07 | 13G | EPIX / ESSA Pharma Inc. | 4,183,223 | |||||
| 2024-10-09 | 13G/A | RPHM / Reneo Pharmaceuticals, Inc. | 3,692,963 | 447,815 | ||||
| 2024-09-25 | 13G | ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) | 4,100,002 | |||||
| 2024-09-16 | 13G | ORMP / Oramed Pharmaceuticals Inc. | 2,048,634 | |||||
| 2024-08-28 | 13G | WHWK / Whitehawk Therapeutics, Inc. | 2,109,942 | 1,383,817 | ||||
| 2024-08-14 | 13G/A | TLIS / Talis Biomedical Corporation | 203,569 | |||||
| 2024-08-14 | 13G/A | ANTX / AN2 Therapeutics, Inc. | 4,249,432 | 5,749,432 | ||||
| 2024-08-14 | 13G | TLIS / Talis Biomedical Corporation | 134,085 | |||||
| 2024-08-12 | 13G | ANTX / AN2 Therapeutics, Inc. | 4,249,432 | |||||
| 2024-07-22 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 1,141,000 | 2,206,346 | ||||
| 2024-05-21 | 13G/A | RPHM / Reneo Pharmaceuticals, Inc. | 1,694,229 | 3,692,963 | ||||
| 2024-05-21 | 13G/A | AVRO / AVROBIO, Inc. | 4,401,627 | 5,168,262 | ||||
| 2024-04-29 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 4,854,252 | 1,141,000 | ||||
| 2024-04-02 | 13G | TIL / Instil Bio, Inc. | 346,190 | |||||
| 2024-03-19 | 13G/A | CYTT / Cyteir Therapeutics, Inc. | 3,470,008 | 3,818,464 | ||||
| 2024-02-08 | 13G/A | ACRS / Aclaris Therapeutics, Inc. | 4,500,000 | 9,395,934 | ||||
| 2024-02-07 | 13G/A | TRML / Tourmaline Bio, Inc. | 245,500 | |||||
| 2024-02-07 | 13G/A | CYTT / Cyteir Therapeutics, Inc. | 2,735,973 | 3,470,008 | ||||
| 2024-02-07 | 13G/A | SRZN / Surrozen, Inc. | 1,669,037 | 0 | ||||
| 2024-02-07 | 13G/A | ABIO / ARCA biopharma, Inc. | 858,256 | 706,930 | ||||
| 2024-02-07 | 13G/A | TLYS / Tilly's, Inc. | 1,234,844 | 0 | ||||
| 2024-02-07 | 13G/A | ELVN / Enliven Therapeutics, Inc. | 50,000 | |||||
| 2024-02-07 | 13G/A | CLYM / Climb Bio, Inc. | 1,897,614 | 2,350,682 | ||||
| 2024-02-07 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 7,300,179 | 4,854,252 | ||||
| 2024-02-07 | 13G/A | CALC / CalciMedica, Inc. | 220,424 | |||||
| 2024-02-07 | 13G/A | QNCX / Quince Therapeutics, Inc. | 1,841,301 | 0 | ||||
| 2024-02-07 | 13G/A | AVRO / AVROBIO, Inc. | 3,965,396 | 4,401,627 | ||||
| 2024-02-07 | 13G/A | AVIR / Atea Pharmaceuticals, Inc. | 4,183,645 | 5,602,079 | ||||
| 2024-02-07 | 13G | AVIR / Atea Pharmaceuticals, Inc. | 4,183,645 | 5,602,079 | ||||
| 2024-01-17 | 13G | RPHM / Reneo Pharmaceuticals, Inc. | 1,694,229 | 1,694,229 | ||||
| 2024-01-16 | 13G | ACRS / Aclaris Therapeutics, Inc. | 4,500,000 | |||||
| 2024-01-11 | 13D/A | FBRX / Forte Biosciences, Inc. | 1,735,075 | 1,761,702 | ||||
| 2023-11-24 | 13G | RAIN / Rain Enhancement Technologies Holdco, Inc. | 1,815,953 | |||||
| 2023-10-02 | 13G | AVIR / Atea Pharmaceuticals, Inc. | 4,183,645 | |||||
| 2023-09-15 | 13D/A | FBRX / Forte Biosciences, Inc. | 1,735,075 | 1,735,075 | ||||
| 2023-07-24 | 13G | AVRO / AVROBIO, Inc. | 3,965,396 | |||||
| 2023-07-17 | 13G | QNCX / Quince Therapeutics, Inc. | 1,841,301 | |||||
| 2023-06-26 | 13D | ASTC / Astrotech Corporation | 232,065 | 232,065 | ||||
| 2023-06-13 | 13G/A | STSA / Satsuma Pharmaceuticals Inc | 6,590,000 | 0 | ||||
| 2023-04-27 | 13G | TALS / Talaris Therapeutics Inc | 2,189,193 | |||||
| 2023-04-27 | 13G | TALS / Talaris Therapeutics Inc | 2,189,193 | |||||
| 2023-03-29 | 13D/A | FBRX / Forte Biosciences, Inc. | 1,461,364 | 1,735,075 | ||||
| 2023-03-17 | 13G | EMBK / Embark Technology Inc - Class A | 994,355 | |||||
| 2023-02-08 | 13G/A | ASTC / Astrotech Corporation | 5,479,322 | 232,065 | ||||
| 2023-02-08 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 1,764,274 | 0 | ||||
| 2023-02-08 | 13G/A | TERN / Terns Pharmaceuticals, Inc. | 1,764,274 | 0 | ||||
| 2023-02-08 | 13G/A | PRDS / Pardes Biosciences Inc | 4,867,984 | 4,867,984 | ||||
| 2023-02-08 | 13G/A | GRAY / Graybug Vision Inc | 1,235,943 | 1,235,943 | ||||
| 2023-02-08 | 13G/A | STSA / Satsuma Pharmaceuticals Inc | 6,440,000 | 6,590,000 | ||||
| 2023-02-08 | 13G/A | ADVM / Adverum Biotechnologies, Inc. | 5,175,500 | 7,300,179 | ||||
| 2023-02-08 | 13G/A | CLYM / Climb Bio, Inc. | 1,739,378 | 1,897,614 | ||||
| 2023-02-08 | 13G/A | IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF | 3,180,000 | 3,337,774 | ||||
| 2023-02-08 | 13G/A | ASTC / Astrotech Corporation | 5,479,322 | 5,479,322 | ||||
| 2023-02-08 | 13G/A | MTCR / Metacrine Inc | 6,488,965 | 6,767,458 | ||||
| 2023-02-08 | 13G/A | TLYS / Tilly's, Inc. | 1,234,844 | 1,234,844 | ||||
| 2023-02-08 | 13G/A | RELL / Richardson Electronics, Ltd. | 710,000 | 95,359 | ||||
| 2023-02-08 | 13G/A | ABIO / ARCA biopharma, Inc. | 761,855 | 858,256 | ||||
| 2023-02-08 | 13G/A | RVP / Retractable Technologies, Inc. | 3,737,500 | 1,056,075 | ||||
| 2023-02-02 | 13G | SRZN / Surrozen, Inc. | 1,669,037 | |||||
| 2023-01-26 | 13G | CYTT / Cyteir Therapeutics, Inc. | 2,735,973 | |||||
| 2023-01-09 | 13G | IRON / Disc Medicine, Inc. | 524,750 | |||||
| 2022-12-30 | 13G | PRDS / Pardes Biosciences Inc | 4,867,984 | |||||
| 2022-12-08 | 13D | MTCR / Metacrine Inc | 5,512,166 | 6,488,965 | ||||
| 2022-12-01 | 13G | GRAY / Graybug Vision Inc | 1,235,943 | |||||
| 2022-11-16 | 13G | STSA / Satsuma Pharmaceuticals Inc | 6,440,000 | |||||
| 2022-10-27 | 13G/A | MTCR / Metacrine Inc | 1,600,000 | 5,512,166 | ||||
| 2022-10-17 | 13G/A | TLYS / Tilly's, Inc. | 737,500 | 1,234,844 | ||||
| 2022-08-25 | 13G/A | ASTC / Astrotech Corporation | 2,587,316 | 5,479,322 | ||||
| 2022-08-16 | 13D/A | FBRX / Forte Biosciences, Inc. | 1,342,391 | 1,461,364 | ||||
| 2022-07-07 | 13D/A | FBRX / Forte Biosciences, Inc. | 1,320,000 | 1,342,391 | ||||
| 2022-06-07 | 13G | TERN / Terns Pharmaceuticals, Inc. | 1,764,274 | |||||
| 2022-05-24 | 13D | FBRX / Forte Biosciences, Inc. | 888,757 | 1,320,000 | ||||
| 2022-05-10 | 13G | ADVM / Adverum Biotechnologies, Inc. | 5,175,500 | |||||
| 2022-05-04 | 13G | ELYM / Eliem Therapeutics, Inc. | 1,739,378 | |||||
| 2022-05-04 | 13G | FBRX / Forte Biosciences, Inc. | 888,757 | |||||
| 2022-05-02 | 13G/A | RVP / Retractable Technologies, Inc. | 2,808,000 | 3,737,500 | ||||
| 2022-04-25 | 13G/A | IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF | 1,632,333 | 3,180,000 | ||||
| 2022-04-14 | 13G | IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF | 1,632,333 | |||||
| 2022-04-13 | 13G/A | GMTX / Gemini Therapeutics Inc | 2,329,699 | 5,270,000 | ||||
| 2022-03-10 | 13G | GMTX / Gemini Therapeutics Inc | 2,329,699 | |||||
| 2022-03-10 | 13G | GMTX / Gemini Therapeutics Inc | 2,329,699 | |||||
| 2022-03-03 | 13G | ASTC / Astrotech Corporation | 2,587,316 | |||||
| 2022-02-18 | 13G | MTCR / Metacrine Inc | 1,600,000 | |||||
| 2022-01-28 | 13G/A | ODT / Odonate Therapeutics Inc | 2,849,657 | |||||
| 2022-01-28 | 13G | ODT / Odonate Therapeutics Inc | 2,849,657 | |||||
| 2022-01-27 | 13G | ABIO / ARCA biopharma, Inc. | 761,855 | |||||
| 2022-01-27 | 13G/A | TLYS / Tilly's, Inc. | 1,350,000 | 737,500 | ||||
| 2022-01-27 | 13G/A | ACRX / Talphera, Inc. | 5,956,000 | 0 | ||||
| 2022-01-27 | 13G/A | RELL / Richardson Electronics, Ltd. | 1,069,186 | 710,000 | ||||
| 2022-01-27 | 13G/A | RVP / Retractable Technologies, Inc. | 1,985,000 | 2,808,000 | ||||
| 2022-01-27 | 13G/A | LUB / Luby`s, Inc. | 1,582,235 | 1,833,268 | ||||
| 2021-07-22 | 13G | LUB / Luby`s, Inc. | 1,582,235 | |||||
| 2021-06-09 | 13G/A | RVP / Retractable Technologies, Inc. | 1,044,494 | 1,985,000 | ||||
| 2021-03-25 | 13G/A | 86858W101 / Support.com, Inc. | 1,158,511 | 0 | ||||
| 2021-02-10 | 13G/A | ISEE / IVERIC bio Inc | 3,751,000 | 3,366,487 | ||||
| 2021-02-10 | 13G/A | RELL / Richardson Electronics, Ltd. | 1,085,000 | 1,069,186 | ||||
| 2021-02-10 | 13G/A | VOXX / VOXX International Corporation | 1,572,894 | 0 | ||||
| 2021-02-10 | 13G/A | 86858W101 / Support.com, Inc. | 1,197,644 | 1,158,511 | ||||
| 2021-02-10 | 13G/A | AADI / Aadi Bioscience, Inc. | 2,290,231 | 2,109,942 | ||||
| 2021-02-10 | 13G/A | RVP / Retractable Technologies, Inc. | 1,747,247 | 1,044,494 | ||||
| 2021-02-10 | 13G/A | TLYS / Tilly's, Inc. | 1,175,860 | 1,350,000 | ||||
| 2021-02-10 | 13G/A | ACRX / Talphera, Inc. | 4,757,803 | 5,956,000 | ||||
| 2020-10-27 | 13G | ACRX / Talphera, Inc. | 4,757,803 | |||||
| 2020-08-21 | 13G | TLYS / Tilly's, Inc. | 1,175,860 | |||||
| 2020-05-12 | 13G/A | RVP / Retractable Technologies, Inc. | 1,557,202 | 1,747,247 | ||||
| 2020-03-09 | 13G | AADI / Aadi Bioscience, Inc. | 2,290,231 | |||||
| 2020-02-11 | 13G/A | JCS / Pineapple Holdings Inc | 542,434 | 0 | ||||
| 2020-02-11 | 13G/A | RELL / Richardson Electronics, Ltd. | 1,079,500 | 1,085,000 | ||||
| 2020-02-11 | 13G/A | RVP / Retractable Technologies, Inc. | 2,352,330 | 1,557,202 | ||||
| 2020-02-11 | 13G/A | VXRT / Vaxart, Inc. | 900,000 | 1,672,906 | ||||
| 2020-02-11 | 13G/A | VOXX / VOXX International Corporation | 1,224,442 | 1,572,894 | ||||
| 2020-02-11 | 13G/A | 86858W101 / Support.com, Inc. | 1,197,644 | 1,197,644 | ||||
| 2020-02-11 | 13G/A | ISEE / IVERIC bio Inc | 3,751,000 | |||||
| 2019-08-22 | 13G | GREE / Greenidge Generation Holdings Inc. | 932,000 | 1,197,644 | ||||
| 2019-07-29 | 13G | VOXX / VOXX International Corporation | 1,224,442 | |||||
| 2019-04-17 | 13G | VXRT / Vaxart, Inc. | 900,000 | |||||
| 2019-04-10 | 13G/A | TIS / Orchids Paper Products Company | 1,063,000 | 1,329,963 | ||||
| 2019-02-06 | 13G/A | TPST / Tempest Therapeutics, Inc. | 3,567,000 | 228,235 | ||||
| 2019-02-06 | 13G/A | RELL / Richardson Electronics, Ltd. | 1,069,000 | 1,079,500 | ||||
| 2019-02-06 | 13G/A | RVP / Retractable Technologies, Inc. | 2,137,540 | 2,352,330 | ||||
| 2019-02-06 | 13G/A | JCS / Pineapple Holdings Inc | 476,770 | 542,434 | ||||
| 2019-02-06 | 13G/A | ISEE / IVERIC bio Inc | 1,849,574 | 2,887,500 | ||||
| 2019-02-06 | 13G/A | TIS / Orchids Paper Products Company | 787,671 | 1,063,000 | ||||
| 2018-11-06 | 13G | JCS / Pineapple Holdings Inc | 476,770 | |||||
| 2018-10-04 | 13G | ISEE / IVERIC bio Inc | 1,849,574 | |||||
| 2018-09-14 | 13D | TPST / Tempest Therapeutics, Inc. | 2,300,000 | 3,567,000 | ||||
| 2018-08-20 | 13G | TIS / Orchids Paper Products Company | 787,671 | |||||
| 2018-03-28 | 13G | TPST / Tempest Therapeutics, Inc. | 2,300,000 | |||||
| 2018-01-31 | 13G/A | BBW / Build-A-Bear Workshop, Inc. | 719,192 | 719,192 | ||||
| 2018-01-31 | 13G/A | RVP / Retractable Technologies, Inc. | 2,137,540 | 2,137,540 | ||||
| 2018-01-31 | 13G/A | RELL / Richardson Electronics, Ltd. | 1,069,000 | 1,069,000 | ||||
| 2018-01-30 | 13G/A | BBW / Build-A-Bear Workshop, Inc. | 1,450,043 | 719,192 | ||||
| 2018-01-30 | 13G/A | RVP / Retractable Technologies, Inc. | 1,959,059 | 2,137,540 | ||||
| 2018-01-30 | 13G/A | RELL / Richardson Electronics, Ltd. | 560,000 | 1,069,000 | ||||
| 2018-01-30 | 13G/A | PRPH / ProPhase Labs, Inc. | 627,322 | 298,302 | ||||
| 2018-01-30 | 13G/A | ZAIS / ZAIS Group Holdings, Inc. | 742,127 | 10,000 | ||||
| 2017-12-04 | 13G | ZAIS / ZAIS Group Holdings, Inc. | 742,127 | |||||
| 2017-11-15 | 13G/A | GREE / Greenidge Generation Holdings Inc. | 936,103 | 932,000 | ||||
| 2017-11-08 | 13G | GREE / Greenidge Generation Holdings Inc. | 936,103 | |||||
| 2017-10-02 | 13G | PRPH / ProPhase Labs, Inc. | 2,322,627 | 627,322 | ||||
| 2017-09-29 | 13G/A | RCKT / Rocket Pharmaceuticals, Inc. | 1,515,092 | 1,325,395 | ||||
| 2017-09-28 | 13G | BBW / Build-A-Bear Workshop, Inc. | 1,450,043 | 1,450,043 | ||||
| 2017-09-28 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 1,450,043 | 1,450,043 | ||||
| 2017-09-27 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 1,450,043 | |||||
| 2017-09-27 | 13G | BBW / Build-A-Bear Workshop, Inc. | 1,450,043 | |||||
| 2017-09-20 | 13G | RCKT / Rocket Pharmaceuticals, Inc. | 1,515,092 | |||||
| 2017-09-05 | 13G/A | MSN / Emerson Radio Corp. | 1,596,382 | 58,962 | ||||
| 2017-03-31 | 13G | RVP / Retractable Technologies, Inc. | 1,959,059 | |||||
| 2017-02-06 | 13G | RELL / Richardson Electronics, Ltd. | 560,000 | |||||
| 2017-02-02 | 13D/A | PRPH / ProPhase Labs, Inc. | 2,322,627 | 2,322,627 | ||||
| 2017-02-01 | 13G/A | MSN / Emerson Radio Corp. | 1,565,546 | 1,596,382 | ||||
| 2017-01-26 | 13G/A | HGGGQ / Hhgregg Inc | 1,910,000 | 0 | ||||
| 2017-01-11 | 13D/A | PRPH / ProPhase Labs, Inc. | 2,322,627 | 2,322,627 | ||||
| 2016-12-22 | 13G | MSN / Emerson Radio Corp. | 1,565,546 | |||||
| 2016-02-11 | 13G/A | HGGGQ / Hhgregg Inc | 1,525,000 | 1,910,000 | ||||
| 2015-05-29 | 13G | HGGGQ / Hhgregg Inc | 1,525,000 | |||||
| 2015-03-09 | 13D | PRPH / ProPhase Labs, Inc. | 2,322,627 | |||||
| 2015-02-05 | 13G/A | PRPH / ProPhase Labs, Inc. | 2,322,627 | |||||
| 2015-01-27 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 1,671,791 | |||||
| 2014-11-14 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 1,931,791 | |||||
| 2014-09-11 | 13G/A | PRPH / ProPhase Labs, Inc. | 1,773,060 | |||||
| 2014-06-03 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 2,252,292 | |||||
| 2014-02-10 | 13G/A | PRPH / ProPhase Labs, Inc. | 966,988 | |||||
| 2013-12-30 | 13G | PRPH / ProPhase Labs, Inc. | 966,988 | |||||
| 2013-01-28 | 13G/A | HLYS / Heelys, Inc. | 2,756,000 | |||||
| 2012-06-22 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 2,640,804 | |||||
| 2012-06-14 | 13G | HLYS / Heelys, Inc. | 1,467,838 | |||||
| 2012-05-21 | 13D/A | BBW / Build-A-Bear Workshop, Inc. | 2,465,804 | |||||
| 2012-02-01 | 13G/A | CPWM / Cost Plus Inc | 960,072 |
